chrX-124022632-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_001042750.2(STAG2):c.5T>C(p.Ile2Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 23)
Consequence
STAG2
NM_001042750.2 missense
NM_001042750.2 missense
Scores
5
5
7
Clinical Significance
Conservation
PhyloP100: 7.45
Genes affected
STAG2 (HGNC:11355): (STAG2 cohesin complex component) The protein encoded by this gene is a subunit of the cohesin complex, which regulates the separation of sister chromatids during cell division. Targeted inactivation of this gene results in chromatid cohesion defects and aneuploidy, suggesting that genetic disruption of cohesin is a cause of aneuploidy in human cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), STAG2. . Gene score misZ 4.938 (greater than the threshold 3.09). GenCC has associacion of gene with Mullegama-Klein-Martinez syndrome.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STAG2 | NM_001042750.2 | c.5T>C | p.Ile2Thr | missense_variant | 3/35 | ENST00000371145.8 | NP_001036215.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAG2 | ENST00000371145.8 | c.5T>C | p.Ile2Thr | missense_variant | 3/35 | 1 | NM_001042750.2 | ENSP00000360187.4 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Cov.: 23
GnomAD4 exome
Cov.:
23
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Mullegama-Klein-Martinez syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 19, 2020 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.;T;.;T;.;T;.;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;D;.;D;.;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;.;L;.;L;L;L;.;.;.
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;N;N;D;N;N;N;N;N;N;N;N
REVEL
Benign
Sift
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;.;D;D;D;D;D;D;D;D
Polyphen
0.99, 0.0040
.;.;D;.;B;.;B;D;B;.;.;.
Vest4
0.62, 0.67, 0.68, 0.64, 0.67
MutPred
Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);Gain of glycosylation at I2 (P = 0.0019);
MVP
MPC
2.6
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at